financetom
Business
financetom
/
Business
/
Cameco Q2 revenue up 47%, net earnings surge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cameco Q2 revenue up 47%, net earnings surge
Jul 31, 2025 4:13 AM

Overview

* Cameco ( CCJ ) Q2 revenue rises 47% yr/yr, reflecting strong uranium segment performance

* Net earnings for Q2 up significantly, driven by Westinghouse investment

* Company's long-term contracting strategy boosts average realized uranium prices

Outlook

* Cameco ( CCJ ) expects uranium average realized price to be C$87 per pound

* Cameco ( CCJ ) sees Westinghouse adjusted EBITDA at $525 mln to $580 mln US

* Company maintains 2025 uranium production target of 18 mln pounds

* Cameco ( CCJ ) notes risks to production schedules and skilled labor availability

Result Drivers

* URANIUM SALES - Higher sales volumes and average realized prices boosted uranium segment earnings

* FUEL SERVICES - Increased sales and decreased costs drove growth in fuel services segment

* WESTINGHOUSE INVESTMENT - Revenue from Czech reactor project significantly improved Westinghouse earnings

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 C$877

Revenue mln

Q2 C$0.71

Adjusted

EPS

Q2 EPS C$0.74

Q2 C$308

Adjusted mln

Net

Income

Q2 Net C$321

Income mln

Q2 Basic C$0.74

EPS

Q2 Gross C$257

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the uranium peer group is "buy"

* Wall Street's median 12-month price target for Cameco Corp ( CCJ ) is C$102.00, about 5.4% below its July 30 closing price of C$107.55

* The stock recently traded at 58 times the next 12-month earnings vs. a P/E of 37 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RBC Reviews TD's Q4, Cuts Target to $77
RBC Reviews TD's Q4, Cuts Target to $77
Dec 6, 2024
01:18 PM EST, 12/06/2024 (MT Newswires) -- TD is undergoing a strategic review which is a significant opportunity for the bank to reevaluate its whole strategy given the constraints under which it must now operate, writes RBC. Target has been trimmed to $77. RBC expects costs to remain elevated through the forecast period. Analyst Darko Mihelic is modelling ~1% core...
Nicolet Bankshares Insider Sold Shares Worth $1,010,785, According to a Recent SEC Filing
Nicolet Bankshares Insider Sold Shares Worth $1,010,785, According to a Recent SEC Filing
Dec 6, 2024
01:10 PM EST, 12/06/2024 (MT Newswires) -- Robert Bruce Atwell, Director, on December 05, 2024, sold 8,945 shares in Nicolet Bankshares ( NIC ) for $1,010,785. Following the Form 4 filing with the SEC, Atwell has control over a total of 33,249 shares of the company, with 32,831 shares held directly and 418 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1174850/000112760224028759/xslF345X05/form4.xml Price: 111.72,...
Stoke Therapeutics Reports Durable Seizure Control With Zorevunersen in Dravet Patient
Stoke Therapeutics Reports Durable Seizure Control With Zorevunersen in Dravet Patient
Dec 6, 2024
01:06 PM EST, 12/06/2024 (MT Newswires) -- Stoke Therapeutics ( STOK ) on Friday released data from Phase 1/2a and open-label extension studies of zorevunersen for the treatment of Dravet syndrome. The data analyzed nine patients who initially received two or three doses of 70 mg, followed by 45 mg maintenance dosing. Patients experienced substantial and sustained reductions in convulsive...
Meta shares hit record high after US appeals court upholds TikTok ban
Meta shares hit record high after US appeals court upholds TikTok ban
Dec 6, 2024
NEW YORK (Reuters) - Shares of Facebook-owner Meta Platforms ( META ) hit a record high on Friday after a U.S. appeals court upheld a law requiring China-based ByteDance to divest its popular short video app TikTok by early next year or face a ban. The decision is a devastating blow to ByteDance, whose social media app is used by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved